NCT07356453
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07356453
Title A Study of PARG Inhibitor FORX-428 in Patients With Advanced Solid Tumors.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors FoRx Therapeutics AG
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University Medical Center RECRUITING Palo Alto California 94304 United States Details
University of California, San Francisco RECRUITING San Francisco California 94143 United States Details
START - Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
Washington University St. Louis RECRUITING St Louis Missouri 63108 United States Details
Knight Cancer Institute RECRUITING Portland Oregon 97239 United States Details
University of Texas - MD Anderson Cancer Center RECRUITING Houston Texas 77030 United States Details
START - San Antonio RECRUITING San Antonio Texas 78229 United States Details
NEXT - Virginia Cancer Specialists RECRUITING Fairfax Virginia 22031 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field